Free Resource in 11 languages! |
The free and comprehensive Guide to Living with Hepatitis B is now available in 11 languages including:
Chinese
Chuukese
French
Korean
Marshallese
Spanish
Swahili
Tagalog
Vietnamese
|
|
Hepatitis B Foundation president responds to J&J ending its hepatitis B drug development program |
Hepatitis B Foundation President Chari A. Cohen, DrPH, MPH, spoke out publicly after news broke that Janssen has decided to shut down its program to develop a drug to treat hepatitis B, which is incurable and infects millions in the U.S. and globally.
Industry publications have reported that J&J plans to walk away from its hepatitis B and D portfolio and pull out of the hepatitis B space.
“This is, of course, disappointing news for us in the hepatitis B and D world,” Dr. Cohen said. “And this serves as a reminder to us, too. Companies operate at the whim of their leadership team and are not beholden to any specific cause." Read more here.
|
|
#justB Open: Bunmi's story |
After her father passed away, Bunmi had to request his death certificate in order to learn the cause of death: liver cancer. She felt stifled by the lack of willingness within her family to talk about hepatitis B, and she wonders if old superstitions about illness in Nigeria are contributing to the stigma surrounding the virus both there and in African immigrant communities in the U.S. She is determined to help end the silence.
|
|
Give us one minute, we'll give you
what you want to read in our blog!
|
The Hepatitis B Foundation Blog is an important source of information for people living with hepatitis B, public health advocates and partners, and the general public. This is why it’s so important to keep our blog relevant and up-to-date with everything hepatitis B related! In an effort to improve our work, we are conducting a short survey to hear from you and create content that matters to you.
Our survey should only take one minute of your time but your responses will make a huge difference in the readership experience. Please click here to complete our survey!
|
|
A quick introduction to public health funding in the U.S. |
This blog by Frank Hood, associate director of public health at the Hepatitis B Foundation, gives an overview of how public health funding works in the US at all levels. This includes federal and state funding, as well as all the levels below.
|
|
Join us for a webinar with Dr. Stephan Urban |
Please join us for a webinar to hear from Dr. Stephan Urban, head of the Translational Virology Unit at the Department of Infectious Diseases at Heidelberg University Hospital and Project Coordinator in the German Center for Infection Research, TTU Hepatitis. Dr. Urban and his team developed the first commercially available and approved drug for hepatitis delta, known as bulevirtide, and he will shed light on the journey of this discovery and how this tremendous medical breakthrough was achieved. The webinar will take place on Thursday, March 9th at 10am Eastern US Time and 4pm Central European Time. We hope to see you there!
|
|
AASLD Summit: Free for people living with hepatitis B |
|
AASLD is offering free registration to those living with hepatitis B, their caregivers and patient advocates. Details and registration are here.
|
|
New "B Heppy" podcast: Hep B related stigma in Nigeria |
On this episode, we get to talk with Danjuma Adda, CEO of TY Danjuma Foundation and current World Hepatitis Alliance President to talk about his experience with viral hepatitis B, hepatitis B related stigma, and his efforts to improve the quality of life for individuals living with hepatitis B.
Please listen here. You can find all the podcast episodes here or anywhere you get your podcasts.
AND, if you'd like to suggest a topic for B Heppy, please send an email to info@hepb.org.
|
|
CHIPO partner highlight:
Hepatitis B Initiative of Washington, D.C.
|
The Coalition Against Hepatitis for People of African Origin (CHIPO) is a community coalition that is co-founded and led by the Hepatitis B Foundation and is made up of organizations and individuals who are interested in addressing the high rates of hepatitis B infection among African communities in the U.S. and globally.
This month, we are excited to highlight the work of one of our partners, the Hepatitis B Initiative of Washington, DC, (HBI-DC), and their new Deputy Executive Director, Sandra Ashford. Please enjoy a recent interview with Sandra, as she describes her work, including successes and challenges, and the positive impact HBI-DC has had by expanding their organization and mission.
Read the full article here.
|
|
Gala ticket sales deadline extended! |
The Hepatitis B Foundation Gala is the organization's signature fundraising event and a truly great time in support of a great cause.
We will be awarding the Blumberg Prize to Stephan Urban, PhD, and the Community Commitment Award to Su Wang, MD, MPH. You won't want to miss it!
You can buy tickets until Jan. 20.
Please get your tickets, before it's too late, here.
|
|
NEW FAQs: new questions that we hear from
people living with hep B on a regular basis
|
The Hep B Foundation Frequently asked Questions page is a wonderful resource for anyone with questions about hepatitis B. The questions are written based on real consults that we receive regularly.
Some topics include: talking to your partner about your diagnosis, functional cure, liver cancer, clinical trials and more.
|
|
New opportunity for people living with hepatitis delta
|
LaGrippe Research is studying the experiences of people with Hepatitis Delta Virus (HDV). They are looking for people with hepatitis D in the U.S., so they can learn what life is like living with the virus.
Participants will join an online community, spending about one hour per month for six months (April-September 2023) and receive $100 per month for participating. Those who choose to participate will answer questions, share thoughts and experiences, and interact anonymously with others. Responses will remain anonymous and be kept confidential. If you're interested in learning more, please complete this form or contact Maggie at 847-373-4104 or maggie@lagripperesearch.com.
|
|
Would you like a copy of the 2022 Donor Impact Report?
Please send a note to Jean Holmes at jean.holmes@hepb.org and put “2022 Impact Report” in the subject line, or call 215-489-4946.
It was a record year!
Learn about the projects our supporters made possible.
|
|
What are your preferences |
Your preferences matter -- please, tell us what you want!
We’re working on a project to learn more about YOUR preferences. If you’d like to be involved, email Jean Holmes at jean.holmes@hepb.org and put “Preferences” in the subject line, or call 215-489-4946.
The goal is to communicate with you what you want, the way you want, and when you want!
|
|
Emerging Scholars Scientific and Medical Advisory Board journal article pick of the month |
|
Autophagic membranes participate in hepatitis B virus nucleocapsid assembly, precore and core protein trafficking, and viral release.
Chu JYK, Chuang YC, Tsai KN, et al.
2022;119(30):e2201927119
|
|
Our presenting emerging scholar is
Mohsin Khan, MSc, PhD, at left.
It is widely known that Hepatitis B virus (HBV) replication is regulated by autophagy. This investigation, led by Prof. Jing-hsiung James Ou at UCLA, has precisely examined and characterized how autophagic membranes participate in the HBV life cycle. Autophagy is a process in which the cells eliminate their organelles and macromolecules. Under normal circumstances, autophagy ensures homeostasis and proper recycling of cellular biomaterials. However, the signaling events of autophagy are often altered during stress, inflammation, and infection. Interestingly many pathogens, especially viruses, have evolved with successful strategies to hijack this cellular process to support their replication. HBV is one among those viruses that are successful invaders and play with autophagic machinery efficiently...Continue reading here.
|
|
March 10 - Baruch S. Blumberg Prize Symposium
Details TBA
March 10 - Hepatitis B Foundation Gala
July 28 - World Hepatitis Day
|
|
Learn more about our research and education programs at www.hepb.org
|
|
The Hepatitis B Foundation is a national nonprofit organization dedicated to finding a cure and improving the quality of life for those affected by hepatitis B worldwide. Our commitment includes funding focused research, promoting disease awareness, supporting immunization and treatment initiatives, and serving as the primary source of information for patients and their families, the medical and scientific community, and the general public. |
|
|
|
Hepatitis B Foundation I 3805 Old Easton Road Doylestown, PA 18902 I
215-489-4900 I info@hepb.org
|
|
|
|
|
|
|
